Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Asia Pacific Investama Tbk. (MYTX) vs Organon Pharma Indonesia Tbk. (SCPI)

Asia Pacific Investama Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Asia Pacific Investama Tbk. dan Organon Pharma Indonesia Tbk.: Asia Pacific Investama Tbk. diperdagangkan di Rp41 (kapitalisasi pasar 348,63 M, volume 24 jam 48,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Asia Pacific Investama Tbk. jauh lebih besar — sekitar 3,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

MYTXSCPI
Kapitalisasi Pasar
348,63 M104,4 M
Volume
48,3 rb
Lot
483

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MYTX
Lihat detail
SCPI
Lihat detail

Tentang Asia Pacific Investama Tbk.

PT Asia Pacific Investama Tbk (the Company) was established in Jakarta originally named PT Mayetexdian Industry1994Change of Majority shareholding amounted for 70% (indirect acquisition), including 40% share investment at PT Pura Golden Lion (rayon fibre distributor).1995Change of the Company’s name to become PT Apac Centertex Corporation, Tbk1996Acquired 94.12% shares of PT Apac Inti Corpora (business line textile) in Bawean – SemarangCompleted internal restructuring – four subsidiaries’ factory-assets (garment industry) grouped altogether and relocated from Jakarta to Semarang.1997Share-investment participation (24%) at PT Vita Daya Harapan (power/steam plant) in Bawen to supply power & steam requirement for PT Apac Inti2000Divestment of share participation (24%) at PT Vita Daya Harapan (power/steam plant) in Bawen to Third PartyNovember 2000, change of the company’s name to become PT Apac Citra Centertex Tbk and qualified approval effective February.

Selengkapnya di halaman MYTX

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI